Diagnocure CUR Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Diagnocure CUR

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Dirks who wrote (85)	8/2/2000 11:54:13 PM
From: john.d	Read Replies (1) of 132

Robert, I'm not so sure about the market drop, but I agree that CUR will be lower later this year. I was thinking that I may try and pick some up during tax loss selling. It would not surprise me if I'm able to pick some up for less than a dollar. However, there is a risk of an important annoucement related to the prostate cancer test, which will boost the price. I'm not worried about any significant rise in the price due to sales of the bladder cancer test, which to date have not materialized. Even if they do make some sales this year, I expect it will be very small and not effect the price. CUR has a long way to go to transform itself from a company that undertakes R&D to actually selling product and generating positive earnings. John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next